Search results
Elon Musk’s X risks fine as EU steps up crackdown on big tech - CNBC TV18
CNBC TV18· 25 minutes agoElon Musk’s social media platform X is set to be served with a formal warning for failing to combat...
Emcure Pharmaceuticals IPO last bidding date today. Should you subscribe? Check GMP, subscription...
Livemint· 22 minutes agoEmcure Pharmaceuticals IPO aims to utilise funds to reduce long-term debt and focus on important therapeutic fields like gynaecology. The IPO is fairly valued, and investors are advised to subscribe for long-term benefits.